Report Summary
Eternity Insights can provide a deep dive research report highlighting the market and competitive in-telligence across the key segments of the market. The report also considers the impact of COVID-19 on the global Antibiotic Resistance market. The report considers 2018-2020 historic period, 2021 as base year, and 2022-2028 as forecast period. The report includes quantitative analysis of the market supported by the mar-ket drivers, challenges, and trends to accurately map the market scenario and competition.
Antibiotic Resistance market report is based on robust research methodology designed using blend of research ap-proaches developed using secondary/desk research and validated through the primary research and expert insights. Eternity Insights also uses paid data bases such as FACIVA, Hoovers, and other bench-marking and forecasting tools to provide accurate statistical analysis of supply and demand trends.
To learn more about this report
Key Research Highlights: Market Drivers
The Antibiotic Resistance market is estimated to expand at a considerable growth rate during the forecast period ow-ing to increasing prevalence of venous diseases and increasing new product approvals to cater this demand. Rise in the awareness about the diseases, increasing importance of early diagnosis, and growing spending on chronic diseases are poised to boost the market growth. Moreover, the key players in the market are investing in research and development of technologically advanced products leading to increased utilization of the Antibiotic Resistance products across developed and developing countries of the world.
Key Research Highlights: Market Restrains
Limited awareness about the diseases, high cost of products, low economical condition, and lack of favorable insurance systems restricts the adoption of Antibiotic Resistance products across developing regions of the globe. However, launch of new products with low cost and increasing efforts for market penetration in these regions can offer lucrative growth opportunities for the players in the Antibiotic Resistance market.
To learn more about this report
Key Research Highlights: Trends
Increasing research and development spending on Antibiotic Resistance development has been the leading industry trend of Antibiotic Resistance market
The leading players in the market are focused on developing products which are cost effective and high quality to tap the huge unaddressed opportunities in the developing regions. This can be wit-nessed from the increasing spending on research and development and growing number of new product approvals.
Global Antibiotic Resistance Market Size, 2018-2028 (USD MILLION)
To learn more about this report
Market Segmentation
| Report Attributes |
Details |
| The market size value in 2021 |
USD XX.XX Million |
| CAGR (2021 - 2028) |
XX.XX % |
| The Revenue forecast in 2028 |
USD XX.XX Million |
| Base year for estimation |
2021 |
| Historical data |
2018-2019 |
| Forecast period |
2022-2028 |
| Quantitative units |
- Revenue in USD Million
- CAGR from 2021 to 2028
|
| Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered |
By Type Outlook, Application Outlook, Regional Outlook |
| By Type Outlook |
Antibiotic Resistance market size by Type, By Disease, Urinary Tract Infection, Intra-Abdominal Infections, Blood Stream Infections, Clostridium Difficile Infections, Acute Bacterial Skin and Skin Structure Infections, Bacterial Pneumonia, By Pathogen, Carbapenem-Resistant, Carbapenem-Resistant, Methicillin-Resistant, Carbapenem-Resistant, Penicillin-Non-Susceptible, Cephalosporin-Resistant, Tetracycline-Resistant, Vancomycin-Resistant, Ampicillin-Resistant |
| By Application Outlook |
Oxazolidinones, Lipoglycopeptides, Tetracyclines, Cephalosporins, Combination therapies, Other |
| Regional scope |
North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Country scope |
U.S., Canada, U.K., Germany, France, BENELUX, China, India, Japan, South Korea, Brazil, Saudi Arabia, UAE, Turkey |
| Key companies profiled |
Allergan, AmpliPhi Biosciences, BioVersys GmbH, Macrolide Pharmaceuticals, Melinta Therapeutics, Merck, Nabriva Therapeutics, Nemesis Bioscience, Phage Technologies S.A, Tetraphase Pharmaceuticals, The Medicines Company, TPfizer, Westway Health |
| Customization Available |
Yes, the report can be tailored to meet your specific requirements. |
Key Market Players
- Allergan
- AmpliPhi Biosciences
- BioVersys GmbH
- Macrolide Pharmaceuticals
- Melinta Therapeutics
- Merck
- Nabriva Therapeutics
- Nemesis Bioscience
- Phage Technologies S.A
- Tetraphase Pharmaceuticals
- The Medicines Company
- TPfizer
- Westway Health
Antibiotic Resistance Market, By Type
- Antibiotic Resistance market size by Type
- By Disease
- Urinary Tract Infection
- Intra-Abdominal Infections
- Blood Stream Infections
- Clostridium Difficile Infections
- Acute Bacterial Skin and Skin Structure Infections
- Bacterial Pneumonia
- By Pathogen
- Carbapenem-Resistant
- Carbapenem-Resistant
- Methicillin-Resistant
- Carbapenem-Resistant
- Penicillin-Non-Susceptible
- Cephalosporin-Resistant
- Tetracycline-Resistant
- Vancomycin-Resistant
- Ampicillin-Resistant
Antibiotic Resistance Market, By Application
- Oxazolidinones
- Lipoglycopeptides
- Tetracyclines
- Cephalosporins
- Combination therapies
- Other
Key Benefits To The Stake Holders
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) and volume (Tons) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Antibiotic Resistance Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibiotic Resistance Market Size Growth Rate by Type
1.4.2 Urinary Tract Infection
1.4.3 Intra-Abdominal Infections
1.4.4 Blood Stream Infections
1.4.5 Clostridium Difficile Infections
1.4.6 Acute Bacterial Skin and Skin Structure Infections
1.4.7 Bacterial Pneumonia
1.5 Market by Application
1.5.1 Global Antibiotic Resistance Market Size Growth Rate by Application
1.5.2 Oxazolidinones
1.5.3 Lipoglycopeptides
1.5.4 Tetracyclines
1.5.5 Cephalosporins
1.5.6 Combination therapies
1.5.7 Other
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Antibiotic Resistance Market Size
2.1.1 Global Antibiotic Resistance Revenue 2017-2027
2.1.2 Global Antibiotic Resistance Sales 2017-2027
2.2 Antibiotic Resistance Growth Rate by Regions
2.2.1 Global Antibiotic Resistance Sales by Regions
2.2.2 Global Antibiotic Resistance Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Antibiotic Resistance Sales by Manufacturers
3.1.1 Antibiotic Resistance Sales by Manufacturers
3.1.2 Antibiotic Resistance Sales Market Share by Manufacturers
3.2 Antibiotic Resistance Revenue by Manufacturers
3.2.1 Antibiotic Resistance Revenue by Manufacturers (2017-2020)
3.2.2 Antibiotic Resistance Revenue Share by Manufacturers (2017-2020)
3.3 Antibiotic Resistance Price by Manufacturers
3.4 Antibiotic Resistance Manufacturing Base Distribution, Product Types
3.4.1 Antibiotic Resistance Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibiotic Resistance Product Type
3.4.3 Date of International Manufacturers Enter into Antibiotic Resistance Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global Antibiotic Resistance Sales by Type
4.2 Global Antibiotic Resistance Revenue by Type
4.3 Antibiotic Resistance Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global Antibiotic Resistance Breakdown Data by Application
6 North America
6.1 North America Antibiotic Resistance by Country
6.1.1 North America Antibiotic Resistance Sales by Country
6.1.2 North America Antibiotic Resistance Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibiotic Resistance by Type
6.3 North America Antibiotic Resistance by Application
7 Europe
7.1 Europe Antibiotic Resistance by Country
7.1.1 Europe Antibiotic Resistance Sales by Country
7.1.2 Europe Antibiotic Resistance Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibiotic Resistance by Type
7.3 Europe Antibiotic Resistance by Application
8 Asia Pacific
8.1 Asia Pacific Antibiotic Resistance by Country
8.1.1 Asia Pacific Antibiotic Resistance Sales by Country
8.1.2 Asia Pacific Antibiotic Resistance Revenue by Country
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibiotic Resistance by Type
8.3 Asia Pacific Antibiotic Resistance by Application
9 Central & South America
9.1 Central & South America Antibiotic Resistance by Country
9.1.1 Central & South America Antibiotic Resistance Sales by Country
9.1.2 Central & South America Antibiotic Resistance Revenue by Country
9.1.3 Brazil
9.1.4 Argentina
9.2 Central & South America Antibiotic Resistance by Type
9.3 Central & South America Antibiotic Resistance by Application
10 Middle East and Africa
10.1 Middle East and Africa Antibiotic Resistance by Country
10.1.1 Middle East and Africa Antibiotic Resistance Sales by Country
10.1.2 Middle East and Africa Antibiotic Resistance Revenue by Country
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibiotic Resistance by Type
10.3 Middle East and Africa Antibiotic Resistance by Application
11 Company Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Company Business Overview
11.1.3 Allergan Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Allergan Antibiotic Resistance Products Offered
11.1.5 Allergan Recent Development
11.2 AmpliPhi Biosciences
11.2.1 AmpliPhi Biosciences Company Details
11.2.2 Company Business Overview
11.2.3 AmpliPhi Biosciences Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.2.4 AmpliPhi Biosciences Antibiotic Resistance Products Offered
11.2.5 AmpliPhi Biosciences Recent Development
11.3 BioVersys GmbH
11.3.1 BioVersys GmbH Company Details
11.3.2 Company Business Overview
11.3.3 BioVersys GmbH Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.3.4 BioVersys GmbH Antibiotic Resistance Products Offered
11.3.5 BioVersys GmbH Recent Development
11.4 Macrolide Pharmaceuticals
11.4.1 Macrolide Pharmaceuticals Company Details
11.4.2 Company Business Overview
11.4.3 Macrolide Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Macrolide Pharmaceuticals Antibiotic Resistance Products Offered
11.4.5 Macrolide Pharmaceuticals Recent Development
11.5 Melinta Therapeutics
11.5.1 Melinta Therapeutics Company Details
11.5.2 Company Business Overview
11.5.3 Melinta Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Melinta Therapeutics Antibiotic Resistance Products Offered
11.5.5 Melinta Therapeutics Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Company Business Overview
11.6.3 Merck Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Merck Antibiotic Resistance Products Offered
11.6.5 Merck Recent Development
11.7 Nabriva Therapeutics
11.7.1 Nabriva Therapeutics Company Details
11.7.2 Company Business Overview
11.7.3 Nabriva Therapeutics Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Nabriva Therapeutics Antibiotic Resistance Products Offered
11.7.5 Nabriva Therapeutics Recent Development
11.8 Nemesis Bioscience
11.8.1 Nemesis Bioscience Company Details
11.8.2 Company Business Overview
11.8.3 Nemesis Bioscience Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Nemesis Bioscience Antibiotic Resistance Products Offered
11.8.5 Nemesis Bioscience Recent Development
11.9 Phage Technologies S.A
11.9.1 Phage Technologies S.A Company Details
11.9.2 Company Business Overview
11.9.3 Phage Technologies S.A Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Phage Technologies S.A Antibiotic Resistance Products Offered
11.9.5 Phage Technologies S.A Recent Development
11.10 Tetraphase Pharmaceuticals
11.10.1 Tetraphase Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Tetraphase Pharmaceuticals Antibiotic Resistance Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Tetraphase Pharmaceuticals Antibiotic Resistance Products Offered
11.10.5 Tetraphase Pharmaceuticals Recent Development
11.11 The Medicines Company
11.12 TPfizer
11.13 Westway Health
12 Future Forecast
12.1 Antibiotic Resistance Market Forecast by Regions
12.1.1 Global Antibiotic Resistance Sales Forecast by Regions 2019-2025
12.1.2 Global Antibiotic Resistance Revenue Forecast by Regions 2019-2025
12.2 Antibiotic Resistance Market Forecast by Type
12.2.1 Global Antibiotic Resistance Sales Forecast by Type 2019-2025
12.2.2 Global Antibiotic Resistance Revenue Forecast by Type 2019-2025
12.3 Antibiotic Resistance Market Forecast by Application
12.4 North America Antibiotic Resistance Forecast
12.5 Europe Antibiotic Resistance Forecast
12.6 Asia Pacific Antibiotic Resistance Forecast
12.7 Central & South America Antibiotic Resistance Forecast
12.8 Middle East and Africa Antibiotic Resistance Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibiotic Resistance Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
